Page last updated: 2024-09-05

sb 203580 and Anoxia, Brain

sb 203580 has been researched along with Anoxia, Brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aguirre, N; Barros-Miñones, L; Goñi-Allo, B; Hervías, I; Orejana, L; Puerta, E; Suquía, V	1

Other Studies

1 other study(ies) available for sb 203580 and Anoxia, Brain

Article	Year
Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate. British journal of pharmacology, 2013, Volume: 168, Issue:8 Topics: Administration, Oral; Animals; Anthracenes; Apoptosis; Hypoxia, Brain; Imidazoles; Male; Malonates; MAP Kinase Signaling System; Neuroprotective Agents; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; Sildenafil Citrate; Sulfonamides	2013

Article

Year

Modulation of the ASK1-MKK3/6-p38/MAPK signalling pathway mediates sildenafil protection against chemical hypoxia caused by malonate.

British journal of pharmacology, 2013, Volume: 168, Issue:8

Topics: Administration, Oral; Animals; Anthracenes; Apoptosis; Hypoxia, Brain; Imidazoles; Male; Malonates; MAP Kinase Signaling System; Neuroprotective Agents; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Pyridines; Rats; Rats, Wistar; Reactive Oxygen Species; Sildenafil Citrate; Sulfonamides

2013